Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Portal Vein Embolization on Patient's Long-term Survival, Complications and Cancer Recurrence.

NCT03168230 is registered in ClinicalTrials.gov with Université de Sherbrooke as lead sponsor.

NCT NCT03168230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03168230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Portal Vein Embolization on Patient's Long-term Survival, Complications and Cancer Recurrence.
Lead sponsor
Université de Sherbrooke
Phase
Observational
Overall status
Completed
Start date
February 27, 2004
Completion date
May 21, 2016
Enrollment
128 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer, liver metastases